ストックスクリーナーアプリを入手
44.25
0.32%
0.14
アフターアワーズ：
44.30
0.05
+0.11%
Sanofi Adr (SNY) 最新ニュース
Sanofi S.A. Stock (FR0000120578): FDA accelerated approval for Tzield puts diabetes franchise in foc - AD HOC NEWS
Communiqué de presse : Le Tzield de Sanofi approuvé aux États-Unis comme première thérapie modificatrice de la maladie pour les patients récemment diagnostiqués avec un diabète de type 1 au stade 3 - GlobeNewswire Inc.
Sanofi S.A. Stock (FR0000120578): Valuation Metrics Under the Microscope - AD HOC NEWS
Sanofi S.A. Stock (FR0000127771): Stock in focus as no fresh trigger is verified - AD HOC NEWS
Sanofi Trial Setback May Reinforce Argenx Vyvgart's Position In CIDP, Analyst Says - Sahm
Sanofi S.A. stock (FR0000127771): Diabetes focus and pipeline news keep Big Pharma in motion - AD HOC NEWS
European ADRs Started The Week In The Green - Finimize
Sanofi S.A. stock (FR0000127771): diabetes deal and pipeline focus move into the spotlight - AD HOC NEWS
Sanofi-Owkin Expand AI Collaboration With New Agentic AI Initiative - Sahm
Senior Chinese legislator meets Myanmar's foreign minister - news.cgtn.com
Sanofi (SASY) Stock: Pharma Giant Launches AI Sales Agent Built on Snowflake - MEXC
SNY Stock Price, Quote & Chart | SANOFI-ADR (NASDAQ:SNY) - ChartMill
Sanofi S.A. stock (FR0000120578): analyst consensus steady as ADRs trade in low-40s USD range - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Analyst consensus points to hold stance as shares hover in low-40s - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Technical picture and price action on Euronext Paris - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Vaccine and obesity focus after Q1 2026 earnings - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 results, pipeline focus and outlook for US investors - AD HOC NEWS
SANOFI-ADR (NASDAQ:SNY): A Quality Dividend Stock with a 5.31% Yield and Strong Fundamentals - ChartMill
Publicis Groupe stock (FR0000120578): LiveRamp deal and AI push keep investors focused - AD HOC NEWS
Publicis Groupe S.A. stock (FR0000120578): LiveRamp deal and AI push reshape data strategy - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): EU green light for multiple myeloma drug Sarclisa draws investor f - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Vaccine unit and new drug launches keep investors alert - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 beat and pipeline focus keep investors watching - AD HOC NEWS
Sanofi stock (FR0000120578): Pipeline updates keep investors watching - AD HOC NEWS
Sanofi stock (FR0000120578): trial data and EU approval updates - AD HOC NEWS
Sanofi stock (FR0000120578): Dupixent data and AI investment keep focus on growth - AD HOC NEWS
Sanofi stock (FR0000120578): FDA, dividend and Dupixent keep investors focused - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Q1 figures, GLP-1 hopes and focus on pipeline value - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Q1 2026 results reviewed - AD HOC NEWS
Sanofi S.A. stock (FR0000120578): Global pharma leader's business and market position - AD HOC NEWS
Sanofi S.A. stock (FR0000127771): Recent earnings and pipeline updates - AD HOC NEWS
Sanofi (NASDAQ:SNY) Emerges as a Decent Value Pick with Strong Fundamentals - ChartMill
Sanofi Supports AlphaDetect to Accelerate Detection of Alpha-1 - ChartMill
European ADRs Open The Week Lower In US Trading - Finimize
Communiqué de presse : Assemblée Générale Annuelle du 29 avril 2026 - GlobeNewswire Inc.
FDA Approval Broadens Dupixent Use While Sanofi Posts Earnings Beat - Sahm
Sanofi Eyes First On-Body Injector Cancer Therapy As FDA Delays Decision - Sahm
Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises - Investing.com
Earnings call transcript: Sanofi’s Q1 2026 earnings beat forecasts, stock rises By Investing.com - Investing.com Canada
0.15%
0.22%
大文字化:
|
ボリューム (24 時間):